Clinical Trial of Quantitative Detection Kit for Hsp90α in Colorectal Cancer

Not Applicable

• Conditions: Colorectal Cancer
• Interventions: Device: Hsp90

• Registration Number: NCT02324114
• Lead Sponsor: Protgen Ltd

Brief Summary

Detect plasma Hsp90α concentration of colorectal cancer patients, healthy volunteers, benign colorectal diseases patients.

Detailed Description

Detect plasma Hsp90α concentration of colorectal cancer patients, healthy volunteers, benign colorectal diseases patients, validate accuracy, specificity and sensitivity of Hsp90α kit.

Study Timeline

• Study Start: 2012-09
• Status Verified: 2014-12
• Primary Completion: 2014-12
• Study Completion: 2014-12
• Study First Submitted: 2014-12-14
• Study First Submitted QC: 2014-12-22
• Last Update Submitted: 2014-12-22
• Study First Posted: 2014-12-24
• Last Update Posted: 2014-12-24

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 1100

Inclusion Criteria

• colorectal cancer patients, healthy volunteers, benign colorectal diseases patients

Exclusion Criteria

• Patients who previously accepted radiotherapy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Rectal cancer	Hsp90	Detect plasma Hsp90α concentration of patients,

Primary Outcome Measures

Name	Time	Method
Hsp90α Concentration(ng/ml) of plasma	4 months	Detect Hsp90α Concentration(ng/ml) of plasma and calculate the accuracy, specificity and sensitivity of Hsp90α kit

Trial Locations

Locations (1)

Shandong province cancer hospital; 🇨🇳 Jinan, Shandong, China